Study of Arka Taila for Wound Healing in Diabetic Foot Ulcer Patients

Clinical Evaluation of Arka Taila in Pramehajanya Vrana (Diabetic Foot Ulcer) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/111217

Enrollment

Registered

2026-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E104- Type 1 diabetes mellitus with neurological complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to sign the consent form. Patients with HbA1c less than 8. Patients having classical features of Prameha janya Vrana (diabetic foot ulcer) will be selected irrespective of gender, religion, occupation, and socio economic status. Dushta Vrana within size of 10 into 10 cm (length into breadth) Patients between the age group of 18-70 years of either sex.

Exclusion criteria

Exclusion criteria: Patient with k/c/o TB, HIV, HCV , HbsAg, VDRL positive. Patients with HbA1c more than 8 Patients with wounds other than Diabetic wounds. Patients suffering from any kind of malignancy Patients suffering from uncontrolled Hypertension. Patient suffering from systemic infectious disease. Patient suffering from osteomyelitis, tubercular ulcer. Patient who fail to give consent.

Design outcomes

Primary

Measure	Time frame
The patient will be assessed on the following parameters 1. Wound Odour 2. Peri Wound Skin 3. Exudates levels 4. Type of Exudates 5. Pain 6. Wound measurements in centimeter square 7. Signs of infectionTimepoint: The patient will be assessed at baseline then at 2nd week, 4th week, 6th week, 8th week, 10th week and then at the completion of trial at 12th week. The follow up will be done 30 days after the completion of trial.	—

Measure

Time frame

The patient will be assessed on the following parameters 1. Wound Odour 2. Peri Wound Skin 3. Exudates levels 4. Type of Exudates 5. Pain 6. Wound measurements in centimeter square 7. Signs of infectionTimepoint: The patient will be assessed at baseline then at 2nd week, 4th week, 6th week, 8th week, 10th week and then at the completion of trial at 12th week. The follow up will be done 30 days after the completion of trial.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Ranjit Singh

Quadra Institute of Ayurveda and Hospital Roorkee

drraji83@yahoo.in9461940996

Outcome results